LLY : Summary for Eli Lilly and Company Common St - Yahoo Finance

U.S. Markets open in 2 hrs 4 mins

Eli Lilly and Company (LLY)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
77.40+0.25 (+0.32%)
At close: 4:00PM EST
People also watch
BMYMRKABTGSKJNJ
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close77.15
Open76.92
Bid0.00 x
Ask0.00 x
Day's Range76.38 - 78.12
52 Week Range64.18 - 84.80
Volume5,602,614
Avg. Volume6,241,132
Market Cap81.2B
Beta0.16
PE Ratio (TTM)33.67
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield2.08 (2.69%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Reuters3 hours ago

    No new antidepressants in sight despite growing need, experts warn

    It is likely to be at least 10 years before any new generation of antidepressants comes to market, despite evidence that depression and anxiety rates are increasing across the world, specialists said on Wednesday. The depression drug pipeline has run dry partly due to a "failure of science" they said, but also due to big pharma pulling investment out of research and development (R&D) in the neuroscience field because the profit potential is uncertain. "I'd be very surprised if we were to see any new drugs for depression in the next decade.

  • PR Newswire3 days ago

    U.S. FDA Extends Review Period for Baricitinib, an Investigational Rheumatoid Arthritis Treatment

    INDIANAPOLIS, Jan. 13, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the U.S. Food and Drug Administration (FDA) has extended the review ...

  • Trump's 'Disastrous' Pharma View Doesn't Rattle JPMorgan Drug Conference
    Investor's Business Daily3 days ago

    Trump's 'Disastrous' Pharma View Doesn't Rattle JPMorgan Drug Conference

    What should investors take away from the JPMorgan Healthcare Conference? Sentiment is "cautiously optimistic."